_id
69148690ccc777a4e85d966c
Ticker
OCEA
Name
Ocean Biomedical Inc.
Exchange
PINK
Address
55 Claverick Street, Providence, RI, United States, 02903
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.oceanbiomedical.com
Description
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment of idiopathic pulmonary fibrosis (IPF) and hermansky-pudlak syndrome (HPS). The company's infectious diseases product candidates for malaria include the ODA-570 vaccine for the prevention of P. falciparum infection; ODA-611 anti-PfGARP mAb for the treatment of Symptomatic P. falciparum infection; and ODA-579 anti-PfGARP small molecule for the treatment of Symptomatic P. falciparum infection. It has license agreement with Elkurt, Inc. for FRG Antibody, bi-specific antibody anti-CTLA4, bispecific (FRG)x anti-PD-1 (FRGxPD-1), chit1 small molecule antifibrotic, and malaria small molecules and antibodies. The company was founded in 2019 and is based in Providence, Rhode Island. Ocean Biomedical, Inc. is a subsidiary of Poseidon Bio, LLC.
Last Close
0.0017
Volume
302
Current Price
0.002
Change
0.0008
Last Updated
2026-01-05T12:00:07.989Z
Image
data:image/webp;base64,UklGRtoAAABXRUJQVlA4IM4AAABQBwCdASpAAEAAPtFgqk6oJaQiLBVY0QAaCWUA00VchUWQc+c6eSkuLXaxYAHeqsNjpfiV1O85Cbsv6Bxhs/aLGLuAAP72UIJC5ZHKpLEmIwBRS/7Y2rjOGREKpto/gLWpeBQhybcoTZFMNdefvhGvTzszTtdMimhQ2s/eLlvD93Kf9/IX32jp/PA/sh9b/vBdvAYnQUgGrAbSjEKWGxiIdqG5TaTmwXdv4nZc8KhoPkXmU6e18HCVfBkQ0p82NJAFWixxu6wAvb83ln8AAA==
Ipo Date
2021-11-08T00:00:00.000Z
Market Cap
232365
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
-
Target Price
18.5
Strong Buy
-
Buy
-
Hold
-
Sell
-
Strong Sell
-
Current Quarter
2025-03-31
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
958000
Operating Income
-958000
Interest Expense
343000
Pretax Income
-8240000
Net Income
-8240000
Eps
-0.29960872336977495
Dividends Per Share
-
Shares Outstanding
232365143
Income Tax Expense
-3301000
EBITDA
-7897000
Operating Margin
-
Total Other Income Expense Net
-7282000
Cash
0
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
1492000
Property Plant Equipment
-
Total Assets
1582000
Payables
964000
Short Term Debt
9350000
Long Term Debt
-
Total Liabilities
93981000
Equity
-92399000
Bs_currency_symbol
USD
Depreciation
1806000
Change In Working Capital
759000
Cash From Operations
-356000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
909000
Net Change In Cash
553000
Cf_currency_symbol
USD
PE
-
PB
-0.0005952994512927629
ROE
8.917845431227612
ROA
-520.8596713021492
FCF
-356000
Fcf Percent
-
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
0.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
0.5
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
0.5
Value Investing Score
1
Quarters > 0 > quarter
2025-03-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
958000
Quarters > 0 > income Statement > operating Income
-958000
Quarters > 0 > income Statement > interest Expense
343000
Quarters > 0 > income Statement > pretax Income
-8240000
Quarters > 0 > income Statement > net Income
-8240000
Quarters > 0 > income Statement > eps
-0.29960872336977495
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
27502537
Quarters > 0 > income Statement > income Tax Expense
-3301000
Quarters > 0 > income Statement > EBITDA
-7897000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-7282000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
0
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1492000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
1582000
Quarters > 0 > balance Sheet > payables
964000
Quarters > 0 > balance Sheet > short Term Debt
9350000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
93981000
Quarters > 0 > balance Sheet > equity
-92399000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-8240000
Quarters > 0 > cash Flow > depreciation
1806000
Quarters > 0 > cash Flow > change In Working Capital
759000
Quarters > 0 > cash Flow > cash From Operations
-356000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
909000
Quarters > 0 > cash Flow > net Change In Cash
553000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.29960872336977495
Quarters > 0 > ratios > PB
-0.0005952994512927629
Quarters > 0 > ratios > ROE
8.917845431227612
Quarters > 0 > ratios > ROA
-520.8596713021492
Quarters > 0 > ratios > FCF
-356000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1753000
Quarters > 1 > income Statement > operating Income
-1753000
Quarters > 1 > income Statement > interest Expense
433000
Quarters > 1 > income Statement > pretax Income
283000
Quarters > 1 > income Statement > net Income
283000
Quarters > 1 > income Statement > eps
0.00811617824481078
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
34868628
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2469000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
0
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
812000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
902000
Quarters > 1 > balance Sheet > payables
799000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
98518000
Quarters > 1 > balance Sheet > equity
-97616000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
283000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-520000
Quarters > 1 > cash Flow > cash From Operations
-2520000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2504000
Quarters > 1 > cash Flow > net Change In Cash
-16000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.00811617824481078
Quarters > 1 > ratios > PB
-0.000714403950172103
Quarters > 1 > ratios > ROE
-0.2899114899196853
Quarters > 1 > ratios > ROA
31.37472283813747
Quarters > 1 > ratios > FCF
-2520000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
47
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
768000
Quarters > 2 > income Statement > operating Income
-768000
Quarters > 2 > income Statement > interest Expense
461000
Quarters > 2 > income Statement > pretax Income
-5528000
Quarters > 2 > income Statement > net Income
-5528000
Quarters > 2 > income Statement > eps
-0.20111118294230826
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
27487283
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-5067000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-4760000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
0
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1042000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1132000
Quarters > 2 > balance Sheet > payables
862000
Quarters > 2 > balance Sheet > short Term Debt
12838000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
99217000
Quarters > 2 > balance Sheet > equity
-98085000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5528000
Quarters > 2 > cash Flow > depreciation
-4299000
Quarters > 2 > cash Flow > change In Working Capital
235000
Quarters > 2 > cash Flow > cash From Operations
-885000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
896000
Quarters > 2 > cash Flow > net Change In Cash
11000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.20111118294230826
Quarters > 2 > ratios > PB
-0.0005604788295865831
Quarters > 2 > ratios > ROE
5.635928021613906
Quarters > 2 > ratios > ROA
-488.339222614841
Quarters > 2 > ratios > FCF
-885000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
28
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
682000
Quarters > 3 > income Statement > operating Income
-682000
Quarters > 3 > income Statement > interest Expense
515000
Quarters > 3 > income Statement > pretax Income
-17234000
Quarters > 3 > income Statement > net Income
-17234000
Quarters > 3 > income Statement > eps
-0.6269808478342512
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
27487283
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-16719000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-16552000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
4000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1277000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
1851000
Quarters > 3 > balance Sheet > payables
926000
Quarters > 3 > balance Sheet > short Term Debt
10980000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
94594000
Quarters > 3 > balance Sheet > equity
-92743000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-17234000
Quarters > 3 > cash Flow > depreciation
-16037000
Quarters > 3 > cash Flow > change In Working Capital
767000
Quarters > 3 > cash Flow > cash From Operations
-290000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-290000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.6269808478342512
Quarters > 3 > ratios > PB
-0.0005927624295095047
Quarters > 3 > ratios > ROE
18.582534530907992
Quarters > 3 > ratios > ROA
-931.0642895732037
Quarters > 3 > ratios > FCF
-290000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
3798000
Annuals > 0 > income Statement > operating Income
-3798000
Annuals > 0 > income Statement > interest Expense
2046000
Annuals > 0 > income Statement > pretax Income
-3301000
Annuals > 0 > income Statement > net Income
-3301000
Annuals > 0 > income Statement > eps
-0.12002529075772174
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
27502537
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-3636000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
0
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
812000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
902000
Annuals > 0 > balance Sheet > payables
799000
Annuals > 0 > balance Sheet > short Term Debt
16300000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
98518000
Annuals > 0 > balance Sheet > equity
-97616000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-9480000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
1043000
Annuals > 0 > cash Flow > cash From Operations
-4180000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
3400000
Annuals > 0 > cash Flow > net Change In Cash
-780000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.12002529075772174
Annuals > 0 > ratios > PB
-0.00036626473221603015
Annuals > 0 > ratios > ROE
3.3816177675790855
Annuals > 0 > ratios > ROA
-365.9645232815964
Annuals > 0 > ratios > FCF
-4180000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
18
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
10214000
Annuals > 1 > income Statement > operating Income
-10214000
Annuals > 1 > income Statement > interest Expense
1762000
Annuals > 1 > income Statement > pretax Income
-114466000
Annuals > 1 > income Statement > net Income
-114466000
Annuals > 1 > income Statement > eps
-3.3035830192842828
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
34649046
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-102490000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
2109000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
5501000
Annuals > 1 > balance Sheet > payables
933000
Annuals > 1 > balance Sheet > short Term Debt
12118000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
96264000
Annuals > 1 > balance Sheet > equity
-90763000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-114466000
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
1181000
Annuals > 1 > cash Flow > cash From Operations
-9429000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
10399000
Annuals > 1 > cash Flow > net Change In Cash
970000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-3.3035830192842828
Annuals > 1 > ratios > PB
-0.0004962788779568766
Annuals > 1 > ratios > ROE
126.11526723444575
Annuals > 1 > ratios > ROA
-2080.8216687874933
Annuals > 1 > ratios > FCF
-9429000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
2481639
Annuals > 2 > income Statement > operating Income
-2481639
Annuals > 2 > income Statement > interest Expense
691
Annuals > 2 > income Statement > pretax Income
-958430
Annuals > 2 > income Statement > net Income
565470
Annuals > 2 > income Statement > eps
0.029724787482777237
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19023517
Annuals > 2 > income Statement > income Tax Expense
-1523900
Annuals > 2 > income Statement > EBITDA
-957739
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1523209
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
328305
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
50000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
467989
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
110911324
Annuals > 2 > balance Sheet > payables
324829
Annuals > 2 > balance Sheet > short Term Debt
2150000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
6613855
Annuals > 2 > balance Sheet > equity
104297469
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-958430
Annuals > 2 > cash Flow > depreciation
1523900
Annuals > 2 > cash Flow > change In Working Capital
1735033
Annuals > 2 > cash Flow > cash From Operations
-747297
Annuals > 2 > cash Flow > capital Expenditures
3
Annuals > 2 > cash Flow > cash From Investing
-2100000
Annuals > 2 > cash Flow > cash From Financing
2100000
Annuals > 2 > cash Flow > net Change In Cash
-747297
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.029724787482777237
Annuals > 2 > ratios > PB
0.00023711574534948684
Annuals > 2 > ratios > ROE
0.542170395333371
Annuals > 2 > ratios > ROA
0.5098397346694734
Annuals > 2 > ratios > FCF
-747300
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
49
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
62345000
Annuals > 3 > income Statement > operating Income
-62345000
Annuals > 3 > income Statement > interest Expense
1000
Annuals > 3 > income Statement > pretax Income
-62344000
Annuals > 3 > income Statement > net Income
-62344000
Annuals > 3 > income Statement > eps
-4.714102079395085
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
13225000
Annuals > 3 > income Statement > income Tax Expense
-1000
Annuals > 3 > income Statement > EBITDA
-62345000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1075602
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1549893
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
108652342
Annuals > 3 > balance Sheet > payables
34444
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
3396444
Annuals > 3 > balance Sheet > equity
105255898
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-62344000
Annuals > 3 > cash Flow > depreciation
236558
Annuals > 3 > cash Flow > change In Working Capital
4741000
Annuals > 3 > cash Flow > cash From Operations
-1053000
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-107100000
Annuals > 3 > cash Flow > cash From Financing
1113000
Annuals > 3 > cash Flow > net Change In Cash
60000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-4.714102079395085
Annuals > 3 > ratios > PB
0.00016334001539752195
Annuals > 3 > ratios > ROE
-59.23088509491411
Annuals > 3 > ratios > ROA
-57.37934300578629
Annuals > 3 > ratios > FCF
-1053000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.29960872336977495
Valuation > metrics > PB
-0.0005952994512927629
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
8.917845431227612
Profitability > metrics > ROA
-552.2788203753352
Profitability > final Score
33
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-2.793002915451895
Risk > final Score
19
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.1446577467519876
Liquidity > metrics > Quick Ratio
0.1446577467519876
Liquidity > final Score
17
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
45
Prev Profitabilities > 1
26
Prev Profitabilities > 2
52
Prev Risks > 0
14
Prev Risks > 1
23
Prev Risks > 2
25
Prev Liquidities > 0
75
Prev Liquidities > 1
14
Prev Liquidities > 2
15
Updated At
2026-01-20T22:19:59.347Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-04-08
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.01
Earnings History > 0 > eps Estimate
-0.24
Earnings History > 0 > eps Difference
0.25
Earnings History > 0 > surprise Percent
104.1667
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-02-26
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0081
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-11-27
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.2011
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-08-28
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.627
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-03-31
Earnings History > 4 > report Date
2024-04-15
Earnings History > 4 > date
2024-03-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.52
Earnings History > 4 > eps Estimate
-0.15
Earnings History > 4 > eps Difference
-0.37
Earnings History > 4 > surprise Percent
-246.6667
Earnings History > 5 > period
2023-12-31
Earnings History > 5 > report Date
2024-02-28
Earnings History > 5 > date
2023-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.4865
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-11-29
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.53
Earnings History > 6 > eps Estimate
-0.15
Earnings History > 6 > eps Difference
-0.38
Earnings History > 6 > surprise Percent
-253.3333
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-08-14
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.41
Earnings History > 7 > eps Estimate
-0.19
Earnings History > 7 > eps Difference
-0.22
Earnings History > 7 > surprise Percent
-115.7895
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-05-24
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.27
Earnings History > 8 > eps Estimate
-0.17
Earnings History > 8 > eps Difference
-0.1
Earnings History > 8 > surprise Percent
-58.8235
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2023-02-23
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.031
Earnings History > 9 > eps Estimate
-0.16
Earnings History > 9 > eps Difference
0.191
Earnings History > 9 > surprise Percent
119.375
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-10-17
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.08
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-07-11
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.01
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-04-25
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2022-01-31
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.04
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-10-18
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment of idiopathic pulmonary fibrosis (IPF) and hermansky-pudlak syndrome (HPS). The company's infectious diseases product candidates for malaria include the ODA-570 vaccine for the prevention of P. falciparum infection; ODA-611 anti-PfGARP mAb for the treatment of Symptomatic P. falciparum infection; and ODA-579 anti-PfGARP small molecule for the treatment of Symptomatic P. falciparum infection. It has license agreement with Elkurt, Inc. for FRG Antibody, bi-specific antibody anti-CTLA4, bispecific (FRG)x anti-PD-1 (FRGxPD-1), chit1 small molecule antifibrotic, and malaria small molecules and antibodies. The company was founded in 2019 and is based in Providence, Rhode Island. Ocean Biomedical, Inc. is a subsidiary of Poseidon Bio, LLC.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOcean Biomedical to be delisted from Nasdaq following appeal denial Investing.com
Read more →Showing 2 of 10
(Last Updated 2025-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Ocean Biomedical Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
0.01
EPS Estimate
-0.24
EPS Difference
0.25
Surprise Percent
104.1667%
(Last Updated 2025-03-31)
(Last Updated 2025-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.